 |
 Video: What is a Stock Split?
|
|
|
| Voyager Therapeutics is a gene therapy company focused on developing treatments and platform technologies. Co.'s team has developed a proprietary adeno-associated virus (AAV) capsid discovery platform called TRACER™ (Tropism Redirection of AAV by Cell Type-Specific Expression of RNA) to facilitate the selection of AAV capsids with blood brain barrier crossing and cell-specific transduction properties for particular therapeutic applications. The TRACER discovery platform is a functional RNA-based AAV capsid discovery platform that allows for rapid in vivo evolution of AAV capsids with cell-specific transduction properties in multiple species, including non-human primates. According to our Voyager Therapeutics stock split history records, Voyager Therapeutics has had 0 splits. | |
|
Voyager Therapeutics (VYGR) has 0 splits in our Voyager Therapeutics stock split history database.
Looking at the Voyager Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Voyager Therapeutics shares, starting with a $10,000 purchase of VYGR, presented on a split-history-adjusted basis factoring in the complete Voyager Therapeutics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/12/2015 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$17.50 |
|
| End price/share: |
$8.81 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-49.66% |
|
| Average Annual Total Return: |
-7.78% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,033.07 |
|
| Years: |
8.48 |
|
|
|
|
|
